WAYNE, Pa.--(BUSINESS WIRE)--Safeguard Scientifics, Inc. (NYSE: SFE), a holding company that builds value in growth-stage life sciences and technology companies, announced today that the Company improved its balance sheet, financial strength and flexibility as a result of Clarient, Inc. (Nasdaq: CLRT) entering into a transaction to issue an aggregate of up to $50 million in convertible preferred stock in a private placement to Oak Investment Partners, a multi-stage venture capital firm based in Westport, CT.
